Mitoxantrone hydrochloride is an anthracenedione antineoplastic agent that functions as a topoisomerase II inhibitor, commonly indicated for the treatment of conditions such as acute myeloid leukemia,… Read more
Mitoxantrone hydrochloride is an anthracenedione antineoplastic agent that functions as a topoisomerase II inhibitor, commonly indicated for the treatment of conditions such as acute myeloid leukemia, prostate cancer, and breast cancer. This category provides a comprehensive selection of reference standards for the parent drug, alongside its pharmacopeial and non-pharmacopeial impurities, including impurities A through D, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials to facilitate rigorous impurity profiling, method validation, and routine quality control testing. By incorporating these analytical standards into their workflows, researchers ensure precise identification and accurate quantification of degradation products and related substances. These compounds are essential for maintaining regulatory compliance and upholding the analytical integrity of pharmaceutical development and manufacturing processes throughout the drug lifecycle.
